Has the time now come to more widely accept hemodiafiltration in the United States?

Journal of the American Society of Nephrology

Volumn 24, Issue 3, 2013, Pages 332-334

  Blankestijn, Peter J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES;

EID: 84874596336     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013010063     Document Type: Editorial

References (13)

1. Maduell F,Moreso F, PonsM, Ramos R,Mora-Macià J, Carreras J, Soler J, Torres F, Campistol J, Martinez-Castelao A; for the ESHOL Study Group: High-efficiency postdilution on-line hemodiafiltration reduces all-cause mortality in hemodialysis patients. J AmSocNephrol 24: 487-497, 2013
2. Tattersall JE, Ward RA; EUDIAL group. Online haemodiafiltration: Definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013, in press
3. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69: 2087-2093, 2006 (Pubitemid 43924275)
4. Blankestijn PJ, Ledebo I, Canaud B: Hemodiafiltration: Clinical evidence and remaining questions. Kidney Int 77: 581-587, 2010
5. GrootemanMP, van den DorpelMA, BotsML, Penne EL, van derWeerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, ter Wee PM, Blankestijn PJ; CONTRAST Investigators: Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23: 1087-1096, 2012
6. Ok E, Asci G, TozH, Sevinc E, Kircelli F, YilmazM,OzkahyaM;On behalf of the 'Turkish Online Haemodiafiltration Study: Mortality and cardiovascular events in online-hemodiafiltration (OL-HDF) compared with high-flux dialysis: Results from the Turkish OL-HDF. Nephrol Dial Transplant 28: 192-202, 2013
7. Blankestijn PJ: Haemodiafiltration: Becoming the new standard? Nephrol Dial Transplant 28: 1-2, 2013
8. Penne EL, van derWeerdNC, BotsML, van denDorpelMA,Grooteman MP, Lévesque R, Nubé MJ, Ter Wee PM, Blankestijn PJ; CONTRAST investigators: Patient-and treatment-related determinants of convective volume in post-dilution haemodiafiltration in clinical practice. Nephrol Dial Transplant 24: 3493-3499, 2009
9. Penne EL, van Berkel T, van derWeerd NC, GrootemanMP, Blankestijn PJ: Optimizing haemodiafiltration: Tools, strategy and remaining questions. Nephrol Dial Transplant 24: 3579-3581, 2009
10. Penne EL, Visser L, van den Dorpel MA, van der Weerd NC, Mazairac AH, van Jaarsveld BC, KoopmanMG, Vos P, FeithGW, KremerHovinga TK, van Hamersvelt HW,Wauters IM, Bots ML, Nubé MJ, TerWee PM, Blankestijn PJ, Grooteman MP: Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int 76: 665-672, 2009
11. Mazairac AH, Blankestijn PJ, GrootemanMP, Penne EL, van derWeerd NC, den Hoedt CH, Buskens E, van den DorpelMA, terWee PM, Nubé MJ, BotsML, de WitGA; on behalf of theCONTRAST investigators: The cost-utility of hemodiafiltration versus hemodialysis in the Convective Transport Study (CONTRAST). Nephrol Dial Transplant 2013, in press
12. Sichart JM, Moeller S: Utilization of hemodiafiltration as treatment modality in renal replacement therapy for end-stage renal disease patients -A global perspective. Contrib Nephrol 175: 163-169, 2011
13. Maduell F,Arias M, DuránCE, VeraM, FontseréN, AzquetaM, RicoN, Pérez N, Sentis A, Elena M, Rodriguez N, Arcal C, Bergadá E, Cases A, Bedini JL, Campistol JM: Nocturnal, every-other-day, online haemodiafiltration: An effective therapeutic alternative. Nephrol Dial Transplant 27: 1619-1631, 2012